Lymphact Alternatives & Competitors

12 companies similar to Lymphact

NantKwest

44 Post-IPO Equity $103.50M

Culver City, United State...

Biotechnology Health Care +1

Altor Bioscience Corporation

1 Private Equity

Biotechnology Health and Wellness +1

Promedior

Pioneering advanced therapies to heal fibrotic and inflammatory diseases at their source,...

Venture round $63.00M

Biopharma Biotechnology +2

Nanoligent

Our mision is to improve the life of patients by designing new drugs that selectively targ...

15 Seed $2.80M

Spain

Biotechnology Pharmaceutical

Track all Lymphact competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Keystone Bio

5 Venture round $5.00M

Saint Louis, United State...

Biotechnology Health Care +1

Rexahn Pharmaceuticals

TARGETING DIFFICULT TO TREAT CANCERS

7 Post-IPO Equity $13.60M

Rockville, United States

Biotechnology Medical Devices +1

PinCell srl

Innovation in Dermatology

6 Seed

Milan, Italy

Biotechnology Health and Wellness +1

Cavion

Empowering therapies for cancer and neurologic diseases through pioneering ion channel inh...

Series A $31.10M

Biotechnology Health Care +1

Hoba Therapeutics

Developing Restorative Treatments for Chronic Neuropathic Pain and Hearing Loss

15 Series A $27.40M

Denmark

Biotechnology Health Care +1

OSE Immunotherapeutics

Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients

76 Grant $53.95M

Nantes, France

Biotechnology Medical Devices +1

Ascelia Pharma AB

Ascelia Pharma is an oncology-dedicated orphan drug company listed on Nasdaq Stockholm und...

16 Post-IPO Equity $200.00M

Malmo, Sweden

Biotechnology Health Care +1

AyuVis Research, Inc.

Innovation in Immunotherapy to Treat Inflammation and Infection

8 Grant $3.90M

Fort Worth, United States

Biopharma Biotechnology +2

Frequently Asked Questions

Companies similar to Lymphact include NantKwest, Altor Bioscience Corporation, Promedior, Nanoligent, Keystone Bio. They work in Biotechnology and Pharmaceutical.

Bounce Watch lists 12 companies that share Lymphact's industries and are closest to it in business tags, services, target customers, business model and size.

Lymphact is a biopharmaceutical startup founded in 2013 in Portugal with a primary focus on personalized treatments targeting cancer and chronic viral diseases. The company's pioneering product is designed to effectively target cancer and virus-infected cells, including chemotherapy-resistant cancer stem cells and vira...

Don't just read about them. Follow them.

BounceWatch watches Lymphact and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Lymphact Profile NantKwest Alternatives Promedior Alternatives Nanoligent Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Lymphact on 14 Sep 2024. The 11 companies listed here were last checked between 11 Sep 2024 and 14 Nov 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.